Contract Development and Manufacturing Organization (CDMO) Wheeler Bio and CRB – a leading global provider of sustainable engineering, architectural, construction and consulting services to the life sciences industry – today announced the start of construction on a GMP drug substance facility that will support innovators seeking agile, small batch manufacturing services for their clinical trial materials (CTM).
Wheeler Bio announces oversubscribed Series A-1, plans for expansion and continued growth
The financing will broaden Wheeler’s capabilities, paving the way for future growth and planned build-out of a 52,000 square foot manufacturing facility.